SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is gaining momentum as market participants track its role as a liquidity hub on the Base ecosystem, with investors closely watching for impact from an upcoming industry event. Community sentiment is largely focused on the potential for long-term utility-driven growth, bolstered by recent partnership announcements and the broader rotation of capital into DeFi assets.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is seeing intense community debate following a weak earnings report, with investors expressing frustration over the lack of capital deployment and the stock's underperformance compared to the broader market. While some shareholders are calling for dividends or aggressive buybacks to counter the stagnation, others remain focused on the company's massive cash pile as a potential defensive play during ongoing geopolitical uncertainty.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is facing intense shareholder scrutiny and calls for strategic alternatives, including a potential company sale, as the stock remains significantly undervalued relative to its cash reserves. Investors are actively coordinating to challenge the board's proposed reverse split and business strategy, expressing frustration over persistent low valuations and management's handling of the company's asset portfolio.

ARK 21Shares Bitcoin ETF - ARK 21Shares Bitcoin ETF Beneficial Interest

ARK 21Shares Bitcoin ETF

The ARK 21Shares Bitcoin ETF (ARKB) is capturing significant attention as investors aggressively rotate into Bitcoin ETFs, with community sentiment buoyed by robust institutional inflows and ongoing discussions about Bitcoin's role as a structural hedge against geopolitical volatility. Traders are actively debating the impact of these institutional flows and monitoring Bitcoin's ability to maintain its support levels, with many viewing the current inflows as a positive signal for long-term momentum.

Maulcoin

Maulcoin is surging in community sentiment as members rally behind its organic growth model and the return of its ticker symbol, with active discussions focusing on smashing resistance levels to reach new market cap milestones. Proponents are highlighting the project's transparent development and community-driven culture as key differentiators from typical pump-and-dump meme coins.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing a surge in investor interest and trading volume as the stock trends near five-year highs, driven by a narrative centered on its pivot toward domestic industrial technology and pharmaceutical manufacturing. While the community is actively debating the potential for government-backed contracts and the validity of a long-term turnaround, many are focused on the stock's role as a play on reshoring essential supplies amidst global supply chain uncertainties.

WorldFinancial

WorldFinancial (WLFI) is currently experiencing intense market volatility and negative sentiment as investors scrutinize ongoing investigations into the project's foreign dealings and potential conflicts of interest. The community remains deeply divided, with some traders viewing the current price weakness as a strategic buying opportunity ahead of upcoming industry forums, while others are warning of a long-term decline and potential fraud.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust is trending as the community debates Bitcoin's long-term macro trajectory, with active discussions focusing on the asset's potential to act as a digital hedge amid broader geopolitical uncertainty and shifts in global monetary policy. Investors remain polarized, balancing optimistic outlooks on institutional adoption and potential price appreciation against concerns over market volatility and the sustainability of current cycles.

The Southern Co is a holding company, which engages in the generation and sale of electricity. It operates through the following segments: Traditional Electric Operating Companies, Southern Power, and Southern Company Gas. The Traditional Electric Operating Companies segment refers to vertically integrated utilities that own generation, transmission and distribution facilities, and supplies electric services in the states of Alabama, Georgia, Florida, and Mississippi. The Southern Power segment constructs, acquires, owns, and manages generation assets such as renewable energy projects and sells electricity in the wholesale market. The Southern Company Gas segment distributes natural gas through natural gas distribution facilities in the states of Illinois, Georgia, Virginia, New Jersey, Florida, Tennessee, and Maryland. The company was founded on November 9, 1945, and is headquartered in Atlanta, GA.

Southern Company

Southern Company remains at the center of investor focus as data center expansion drives significant, long-term electricity demand across its service regions. While the stock continues to attract attention for its role in AI-driven energy infrastructure, community discussion is currently balancing this growth potential against concerns over rising utility bills and volatility from recent executive share sales.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token (VVV) is surging as community members highlight its role as a decentralized, uncensored AI platform with deflationary tokenomics driven by regular token burns and reduced supply emissions. Investors are actively discussing the stock's strong relative momentum and potential for a breakout into double-digit prices, citing the platform's integration of advanced AI models and growing utility as primary long-term catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $19.00 at Royal Bank Of Canada

Royal Bank Of Canada lifted their price target on shares of Sarepta Therapeutics from $18.00 to $19.00 and gave the company a "sector perform" rating in a research report on Tuesday...

Aberdeen Group plc Increases Stake in Sarepta Therapeutics, Inc. $SRPT

Aberdeen Group plc increased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 13.6% in the fourth quarter, according to the company in its most recent filing with...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 31, 2026 that were previously approved by the Compensation...

Mirador Capital Partners LP Invests $3.01 Million in Sarepta Therapeutics, Inc. $SRPT

Mirador Capital Partners LP purchased a new position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 139,982 shares of the biotechnology company's stock, valued at approximately $3...

Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?

Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Get Free Report) have earned an average rating of "Hold" from the twenty-eight brokerages that are currently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a sell rating, thirteen have issued a hold ratin...

Sarepta Therapeutics (NASDAQ:SRPT) Stock Price Down 8% - Here's What Happened

Sarepta Therapeutics (NASDAQ:SRPT) Shares Down 8% - Here's What Happened...

SRPT Stock Surges on Promising Early Results From siRNA Programs

Sarepta Therapeutics shares surge 35% as early data from two siRNA therapies show strong target knockdown, safety and muscle delivery potential.

Sarepta Therapeutics (NASDAQ:SRPT) Given New $13.00 Price Target at Citigroup

Citigroup boosted their target price on shares of Sarepta Therapeutics from $9.00 to $13.00 and gave the stock a "sell" rating in a research report on Thursday...

Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?

Sarepta Therapeutics (SRPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

SRPT
Sarepta Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SRPT News

SRPTSarepta Therapeutics Inc